Skip to content
Homepage
Category:
Globe Newswire
Posted Date:
June 7, 2026
Antag Therapeutics presents positive Phase 1 results at the 2026 Scientific Sessions of the American Diabetes Association for AT7687, a first-in-class GIPR antagonist
Antag Therapeutics
June 7, 2026
Bronstein, Gewirtz & Grossman LLC Urges CommVault Systems, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman, LLC
June 7, 2026
Bronstein, Gewirtz & Grossman LLC Urges Lucid Group, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman, LLC
June 7, 2026
Bronstein, Gewirtz & Grossman LLC Urges Stellantis N.V. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman, LLC
June 7, 2026
Bronstein, Gewirtz & Grossman LLC Urges Immutep Limited Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman, LLC
June 7, 2026
Bronstein, Gewirtz & Grossman LLC Urges Regencell Bioscience Holdings Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman, LLC
June 7, 2026
Bronstein, Gewirtz & Grossman LLC Urges Phreesia, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman, LLC
June 7, 2026
Bronstein, Gewirtz & Grossman LLC Urges POET Technologies Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman, LLC
June 7, 2026
Bronstein, Gewirtz & Grossman LLC Urges Calix, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman, LLC
June 7, 2026
Bronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings Corp. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman, LLC
June 7, 2026
Bronstein, Gewirtz & Grossman LLC Urges SES AI Corporation Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman, LLC
June 7, 2026
Dietz & Watson Expands Its Premium Deli Chicken Lineup with Launch of Heritage Roast and Cantina Chicken Breast at IDDBA 2026
Dietz & Watson
June 7, 2026
MemeToro Price Prediction: $1 Talk Returns as Presale Buyers Bet on MemeToro AI Agent Solutions
MemeToro AI Labs
June 7, 2026
See What the Market Is Talking About — Before It Moves
Market IQ Media Group Incorporated
June 7, 2026
Crypto News Today: AlphaPepe Presale Hits 9300 Holders While Bitcoin Price Prediction Targets $50,000
AlphaPepe
June 6, 2026
Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems
Senseonics Holdings, Inc.
June 6, 2026
Cyndee Haydon Named Among 2026 Best Real Estate Agents in the United States by RealTrends, Ranking #723 in Florida Out of 232,000 Realtors
Sandbars To Sunsets Team with Future Home Realty
June 6, 2026
Are AI Crypto Trading Bots Suitable for Crypto Beginners? BulkQuant Launches an Automated Crypto Trading App
BulkQuant
June 6, 2026
All In FutureTech Alliance Provides Strategic Updates: Hainan AIFA Digital Industrial Park, Silicon Photonics Compute Center Planning, and Cross-Border Optical Network Integration
All In FutureTech Alliance, Inc.
June 6, 2026
Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress
Cullinan Therapeutics, Inc.
June 6, 2026
JEF INVESTIGATION: Robbins Geller Rudman & Dowd LLP Launches Investigation into Jefferies Financial Group, Inc. and Encourages Investors and Potential Witnesses to Contact Law Firm
Robbins Geller Rudman & Dowd LLP
June 5, 2026
SHARE3DCAM Launches AI Engine Algorithm Upgrade in SHARE PointClouds Studio V2.5.0, Advancing the Complete Scan-to-Deliverable Workflow for AEC and Renovation Professionals
SHARE3DCAM
June 5, 2026
Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Bluejay Diagnostics, Inc.
June 5, 2026
All-Round for Work & Play: KTC Dual-Mode Monitor H27P6 Adapts to Full-Scenario Needs
KTC TECHNOLOGY (HONGKONG) CO., LIMITED
June 5, 2026
NatureU® Now Has Three Clinical Studies Publicly Registered on ClinicalTrials.gov as 56-Day PQQ Skin-Aging Study (NCT07571629) Joins Two Previously Published Peer-Reviewed Trials
NatureU®
June 5, 2026
Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study
Biomea Fusion, Inc.
June 5, 2026
DentaQuest Data Breach: Edelson Lechtzin LLP Launches Investigation Into Exposure of Personal Information
Edelson Lechtzin LLP
June 5, 2026
Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026
Kailera Therapeutics, Inc.
June 5, 2026
Oban BioPharma Announces Presentation of Late-Breaking Abstract at ADA 2026 Highlighting OBT-676: A First-in-Class Small Molecule Combining Dual Amylin and Calcitonin Receptor Full Agonism (DACRA) with GLP-1, GIP and Glucagon (Triple-G) Receptor Partial Agonism
Oban BioPharma, Inc.
June 5, 2026
Prev
1
…
267
268
269
